Arvinas Inc reports results for the quarter ended March 31 - Earnings Summary

• Arvinas Inc ARVN.OQ reported quarterly adjusted earnings of $1.14​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -97 cents. The mean expectation of seventeen analysts for the quarter was for a loss of 95 cents per share. Wall Street expected results to range from $-1.35 to -51 cents per share.

• Revenue rose 646.2% to $188.80 million from a year ago; analysts expected $41.59 million.

• Arvinas Inc's reported EPS for the quarter was $1.14​.

• The company reported quarterly net income of $82.9 million.

• Arvinas Inc shares had risen by 37.0% this quarter and lost 49.8% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 24.8% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 16 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for Arvinas Inc is $25.00

This summary was machine generated from LSEG data May 1 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)